Blue Jet Healthcare Ltd
Ticker: BLUEJET
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
656.40
Market Cap
11386.27
Debt/Equity
0.0190
ROE %
30.854
PB
10.0487
Promoter %
79.812
Pledge %
0.000
1Y Rev Growth %
45.349
5Y Rev Growth %
14.624
NP Margin %
28.358
NP Margin 5Y Avg %
25.138
Trading Reference
1M Return %
1.633
6M Return %
-9.243
1Y Return %
38.832
% Away 52W High
56.581
% Away 52W Low
41.557
Daily Volume
212671
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 25/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Blue Jet Healthcare Ltd shows strong growth potential in the healthcare sector, driven by increasing demand for healthcare services and innovative product offerings.
✅ Positives
- Strong revenue growth in recent quarters
- Expanding product portfolio and market presence
- Robust demand in healthcare sector
⚠️ Negatives
- High competition in the healthcare market
- Regulatory challenges may impact operations
- Dependence on key suppliers for raw materials
Verdict
Moderate growth potential with manageable risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
V
Vardhman Textiles Ltd
Vardhman Textiles shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
C
Clean Science and Technology Ltd
Clean Science and Technology Ltd shows decent potential with consistent growth and profitability metrics, but valuation concerns and execution risks should be monitored.
View details
G
G R Infraprojects Ltd
G R Infraprojects Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
R
Relaxo Footwears Ltd
Relaxo Footwears Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
I
Ingersoll-Rand (India) Ltd
Ingersoll-Rand (India) Ltd shows decent potential with a strong market position, but faces challenges in profitability and valuation metrics.
View details
I
India Cements Ltd
India Cements Ltd shows potential but faces challenges in growth consistency and valuation compared to peers.
View details
G
Gravita India Ltd
Gravita India Ltd shows potential for growth in a favorable sector, but investors should be cautious of execution risks and liquidity issues.
View details
L
Le Travenues Technology Ltd
Le Travenues Technology Ltd shows potential for growth but faces challenges in profitability and execution risks. Investors should proceed with caution.
View details
M
Minda Corporation Ltd
Minda Corporation Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India Ltd shows potential but faces challenges in profitability and execution risks.
View details
R
Railtel Corporation of India Ltd
Railtel Corporation of India Ltd shows potential in a growing sector with a decent balance sheet, but faces challenges in profitability and execution risks.
View details
J
Jyothy Labs Ltd
Jyothy Labs Ltd shows potential for moderate growth but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
C
CCL Products (India) Ltd
CCL Products shows potential for growth but faces challenges in profitability and valuation metrics.
View details
A
Acutaas Chemicals Ltd
Acutaas Chemicals Ltd shows potential but faces significant challenges in growth consistency and market sentiment.
View details
U
Usha Martin Ltd
Usha Martin Ltd presents a risky investment profile with inconsistent growth and moderate profitability metrics. Caution is advised.
View details
E
Engineers India Ltd
Engineers India Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
Business Overview
Blue Jet Healthcare Ltd is a leading player in the Indian healthcare sector, specializing in the manufacturing and distribution of high-quality pharmaceutical products. Catering to hospitals, clinics, and pharmacies, the company is dedicated to improving patient outcomes through innovative solutions. With a strong focus on quality and compliance, Blue Jet Healthcare is committed to meeting the evolving needs of the healthcare industry.
- Established leader in the Indian healthcare market
- Specializes in high-quality pharmaceutical products
- Focus on innovation and patient outcomes
- Strong compliance with industry standards
- Trusted by hospitals, clinics, and pharmacies
Investment Thesis
Blue Jet Healthcare Ltd stands out as a compelling investment due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth and value creation in the healthcare sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Robust growth runway in digital healthcare services aligns with market trends.
- Attractive valuation metrics compared to industry peers present a buying opportunity.
- Focus on innovation and quality positions Blue Jet for long-term success.
- Strategic partnerships and expansions bolster market presence and revenue potential.
Opportunity vs Risk
Opportunities
- Growing healthcare demand in India
- Expansion into new markets
- Innovative product offerings
- Strong management team
- Potential for strategic partnerships
Risks ⚠️
- Regulatory changes impacting operations
- High competition in healthcare sector
- Supply chain disruptions
- Economic downturn affecting spending
- Dependence on key suppliers
Peer Perspective
Blue Jet Healthcare Ltd trades at a slight premium to peers like Suven Pharmaceuticals and Granules India, reflecting its growth potential. A sustained improvement in margins could trigger a rerating, aligning it closer to industry leaders.
Future Outlook
Blue Jet Healthcare Ltd is well-positioned for growth, driven by strong demand in the healthcare sector. However, successful execution of its strategic initiatives and effective cost control will be crucial for maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Blue Jet Healthcare Ltd do?A: Blue Jet Healthcare Ltd focuses on manufacturing and distributing pharmaceutical products and healthcare solutions.
- Q: Is Blue Jet Healthcare Ltd a good investment?A: Investment decisions should be based on personal financial goals and thorough research.
- Q: What are the risks of investing in Blue Jet Healthcare Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of Blue Jet Healthcare Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Does Blue Jet Healthcare Ltd pay dividends?A: Check the company's latest financial reports for information on dividend payments.
📊 Stock Investment Checklist (100 Points)
Blue Jet Healthcare Ltd • Updated: 2025-09-16 20:00:33
-
10BusinessHighThe healthcare sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above peers.
-
6BalanceGoodModerate debt levels, liquidity is acceptable.
-
7GovernanceHighPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Blue Jet Healthcare Ltd shows potential for growth but faces significant challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100